|
|
 |
|
 |
 |
"Zometa gives our members treatment options for hypercalcemia of malignancy, multiple myeloma and patients with documented bone metastases from solid tumors, in conjunction with standard antineoplastic therapy."
- Dennis Wollschleger
- CEO, Oncology Associates |
 |
 |
|
|
 |
|
|
 |
 |
 |
|
 |
| Novartis Oncology is exploring a number of novel compounds in various stages of development, and is pioneering exciting areas such as signal transduction inhibition, anti-angiogenesis, and others that are likely to change the way cancer is treated in the future. As part of the clinical development process, we are integrating new technologies to assess the disease state, guide therapy, and monitor the clinical response to our novel compounds. |
|
| Product Contracts Offered Through OA: |
|
|
|
|
 |
 |
|
